A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
ITEM 1. BUSINESS Danaher is a global science and technology innovator committed to accelerating the power of science and technology to improve human health. Danaher is comprised of more than 15 operating companies with leadership positions in the biotechnology, life sciences and diagnostics sectors, organized under three segments (Biotechnology, Life Sciences and Diagnostics). United by the DANAHER BUSINESS SYSTEM (“DBS”), our businesses are also typically characterized by a high level of products and services that are sold on a recurring basis, primarily through a direct sales model and to a geographically diverse customer base. Our business’ research and development, manufacturing, sales, distribution, service and administrative facilities are located in approximately 50 countries.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 24.6B | 24.6B | 23.9B | 23.9B | 26.6B | 29.5B |
| Net Income | 3.6B | 3.6B | 3.9B | 4.7B | 7.1B | 6.3B |
| EPS | $5.05 | $5.05 | $5.29 | $6.38 | $8.56 | $7.63 |
| Free Cash Flow | 5.3B | 5.3B | 5.3B | 5.8B | 7.4B | 7.1B |
| ROIC | 6.0% | 6.1% | 6.4% | 6.4% | 10.4% | 9.6% |
| Gross Margin | 59.1% | 59.1% | 59.5% | 58.7% | 60.8% | 61.0% |
| Debt/Equity | 0.35 | 0.35 | 0.33 | 0.38 | 0.40 | 0.49 |
| Dividends/Share | $1.23 | $1.23 | $1.04 | $1.10 | $0.99 | $0.90 |
| Operating Income | 4.7B | 4.7B | 4.9B | 5.2B | 7.5B | 7.5B |
| Operating Margin | 19.1% | 19.1% | 20.4% | 21.8% | 28.3% | 25.3% |
| ROE | 6.9% | 7.1% | 7.9% | 8.9% | 14.2% | 13.9% |
| Shares Outstanding | 716M | 716M | 737M | 743M | 829M | 821M |
DANAHER CORP /DE/ passes 5 of 9 quality checks, suggesting mixed fundamentals.
DANAHER CORP /DE/ trades at 38.8x trailing earnings, compared to its 15-year median P/E of 36.5x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 26.3x vs a median of 29.3x. The company's 5-year average ROIC is 7.8% with a gross margin of 59.8%. Total shareholder yield (dividends + buybacks) is 2.8%. At current prices, the estimated annualized return to fair value is +9.5%.
DANAHER CORP /DE/ (DHR) has a current P/E ratio of 38.8, compared to its historical median P/E of 36.5. The stock is currently considered Fair based on its historical valuation range.
DANAHER CORP /DE/ (DHR) has a 5-year average return on invested capital (ROIC) of 7.8%. This is below average and may indicate limited pricing power.
DANAHER CORP /DE/ (DHR) has a market capitalization of $140.2B. It is classified as a large-cap stock.
Yes, DANAHER CORP /DE/ (DHR) pays a dividend with a trailing twelve-month yield of 0.63%. The company also returns capital through share buybacks, with a buyback yield of 2.20%.
Based on historical P/E analysis, DANAHER CORP /DE/ (DHR) appears fair. The current P/E of 38.8 is 6% above its historical median of 36.5. The estimated fair value CAGR (P/E method) is 9.3%.
DANAHER CORP /DE/ (DHR) operates in the Industrial Instruments For Measurement, Display, And Control industry, within the Technology sector.
DANAHER CORP /DE/ (DHR) reported annual revenue of $24.6 billion in its most recent fiscal year, based on SEC EDGAR filings.
DANAHER CORP /DE/ (DHR) has a net profit margin of 14.7%. This is a healthy margin.
DANAHER CORP /DE/ (DHR) generated $5.3 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
DANAHER CORP /DE/ (DHR) has a debt-to-equity ratio of 0.35. This indicates a conservatively financed balance sheet.
DANAHER CORP /DE/ (DHR) reported earnings per share (EPS) of $5.05 in its most recent fiscal year.
DANAHER CORP /DE/ (DHR) has a return on equity (ROE) of 7.1%. This indicates moderate shareholder returns.
DANAHER CORP /DE/ (DHR) has a 5-year average gross margin of 59.8%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 19 years of financial data for DANAHER CORP /DE/ (DHR), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
DANAHER CORP /DE/ (DHR) has a book value per share of $73.41, based on its most recent annual SEC filing.
No recent press releases.